Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arlen

Showing results (61-70 of 215) with videos related to

Pageof 22
Sort By:
Urology|July 1, 2014
Current trends in dextranomer hyaluronic acid copolymer (Deflux) injection technique for endoscopic treatment of vesicoureteral refluxAndrew J Kirsch, Angela M Arlen, Goran Lackgren
Seminars in Oncology|December 13, 2005
Pox viral vaccine approachesPhilip M Arlen, Howard L Kaufman, Robert S DiPaola
Vaccine|June 19, 2007
Enhancing efficacy of therapeutic vaccinations by combination with other modalitiesJames L Gulley, Ravi A Madan, Philip M Arlen
Gynakologische Rundschau|January 1, 1976
[Breast neoplasms: a microcarcinoma in the second breast]J Fenig, M Arlen, S F Livingston, et al.
Expert Opinion on Biological Therapy|March 22, 2007
PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinomaRavi A Madan, Philip M Arlen, James L Gulley
Journal of Pediatric Urology|January 3, 2012
Asymptomatic chronic partial obstruction of a normal ureter following dextranomer/hyaluronic acid copolymer (Deflux®) injection for grade I vesicoureteral refluxAngela M Arlen, Brittany L Pakalniskis, Christopher S Cooper
American Journal of Surgery|March 1, 1976
Nodal response in medullary carcinoma of the breastM Arlen, L Flores, A Elguezbal, et al.
Hematology/Oncology Clinics of North America|July 25, 2006
Immunotherapy for prostate cancer: what's the future?Philip M Arlen, William L Dahut, James L Gulley
Thescientificworldjournal|January 25, 2011
Sacral neuromodulation for refractory urge incontinence is less effective following spinal surgeryAngela M Arlen, Charles R Powell, Karl J Kreder
The Oncologist|May 25, 2006
Therapeutic vaccines for prostate cancerChristopher P Tarassoff, Philip M Arlen, James L Gulley
Pageof 22

Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Urology|July 1, 2014
Current trends in dextranomer hyaluronic acid copolymer (Deflux) injection technique for endoscopic treatment of vesicoureteral refluxAndrew J Kirsch, Angela M Arlen, Goran Lackgren
Seminars in Oncology|December 13, 2005
Pox viral vaccine approachesPhilip M Arlen, Howard L Kaufman, Robert S DiPaola
Vaccine|June 19, 2007
Enhancing efficacy of therapeutic vaccinations by combination with other modalitiesJames L Gulley, Ravi A Madan, Philip M Arlen
Gynakologische Rundschau|January 1, 1976
[Breast neoplasms: a microcarcinoma in the second breast]J Fenig, M Arlen, S F Livingston, et al.
Expert Opinion on Biological Therapy|March 22, 2007
PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinomaRavi A Madan, Philip M Arlen, James L Gulley
Journal of Pediatric Urology|January 3, 2012
Asymptomatic chronic partial obstruction of a normal ureter following dextranomer/hyaluronic acid copolymer (Deflux®) injection for grade I vesicoureteral refluxAngela M Arlen, Brittany L Pakalniskis, Christopher S Cooper
American Journal of Surgery|March 1, 1976
Nodal response in medullary carcinoma of the breastM Arlen, L Flores, A Elguezbal, et al.
Hematology/Oncology Clinics of North America|July 25, 2006
Immunotherapy for prostate cancer: what's the future?Philip M Arlen, William L Dahut, James L Gulley
Thescientificworldjournal|January 25, 2011
Sacral neuromodulation for refractory urge incontinence is less effective following spinal surgeryAngela M Arlen, Charles R Powell, Karl J Kreder
The Oncologist|May 25, 2006
Therapeutic vaccines for prostate cancerChristopher P Tarassoff, Philip M Arlen, James L Gulley
Pageof 22